| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-02-11 | STATE STREET CORP | MYRIAD GENETICS INC | - | 5.5% | EDGAR |
| SC 13G/A | 2022-02-11 | EARNEST PARTNERS LLC | MYRIAD GENETICS INC | 6,316,365 | 7.9% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | MYRIAD GENETICS INC | 9,149,521 | 11.5% | EDGAR |
| SC 13G | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | MYRIAD GENETICS INC | 4,325,775 | 5.4% | EDGAR |
| SC 13G/A | 2022-01-27 | BlackRock Inc. | MYRIAD GENETICS INC | 14,684,787 | 18.4% | EDGAR |
| SC 13G | 2022-01-26 | BlackRock Inc. | MYRIAD GENETICS INC | 14,684,787 | 18.4% | EDGAR |
| SC 13G/A | 2021-02-16 | STATE STREET CORP | MYRIAD GENETICS INC | - | 4.9% | EDGAR |
| SC 13G/A | 2021-02-16 | D. E. SHAW & CO, L.P. | MYRIAD GENETICS INC | 3,215,449 | 4.3% | EDGAR |
| SC 13G/A | 2021-02-16 | Camber Capital Management LP | MYRIAD GENETICS INC | - | - | EDGAR |
| SC 13G | 2021-02-16 | EARNEST PARTNERS LLC | MYRIAD GENETICS INC | 6,731,429 | 9.0% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | MYRIAD GENETICS INC | 8,296,864 | 11.0% | EDGAR |
| SC 13G | 2021-01-25 | BlackRock Inc. | MYRIAD GENETICS INC | 12,501,920 | 16.6% | EDGAR |
| SC 13G/A | 2020-07-07 | BAILLIE GIFFORD & CO | MYRIAD GENETICS INC | 0 | 0.0% | EDGAR |
| SC 13G | 2020-06-22 | Camber Capital Management LP | MYRIAD GENETICS INC | - | - | EDGAR |
| SC 13G | 2020-06-15 | D. E. SHAW & CO, L.P. | MYRIAD GENETICS INC | 3,791,528 | 5.1% | EDGAR |
| SC 13G/A | 2020-06-04 | BAILLIE GIFFORD & CO | MYRIAD GENETICS INC | 4,046,168 | 5.4% | EDGAR |
| SC 13G/A | 2020-02-14 | D. E. SHAW & CO, L.P. | MYRIAD GENETICS INC | 2,868,414 | 3.9% | EDGAR |
| SC 13G | 2020-02-14 | STATE STREET CORP | MYRIAD GENETICS INC | - | 5.2% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | MYRIAD GENETICS INC | 8,320,574 | 11.2% | EDGAR |
| SC 13G/A | 2020-02-04 | BlackRock Inc. | MYRIAD GENETICS INC | 12,752,119 | 17.1% | EDGAR |